← Back to home

PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS)

Clinical trials for PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS) explained in plain language.

Never miss a new study

Get alerted when new PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS) trials appear

Sign up with your email to follow new studies for PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail tested for Tough-to-Treat brain cancers

Disease control Ongoing

This early-phase study is testing the safety of a combination of five drugs (called VIPOR) for people with aggressive B-cell lymphomas that involve the brain or spinal cord. The trial is for adults whose cancer has come back, stopped responding to treatment, or who cannot receive…

Matched conditions: PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS)

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:42 UTC

PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS)

Get alerted when new PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (CNS) trials appear

New drug cocktail tested for Tough-to-Treat brain cancers